| Name | Tersigat |
|---|---|
| Synonyms |
oxytropiumbromide
Scopolamine ethobromide oxytropium bromide ba253br (-)-n-ethyl-norhyoscine-methobromide OXITROPIUM BROMIDE Oxitropium bromurodeoxitropio (1R,2R,4S,5S,7s,9R)-9-ethyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide Oxitropium bromide Ba-253-BR-L oxitropium N-Ethylnorscopolamine-methyl bromide enylpropoxy)-9-methyl-,bromide,(7(s)-(1-alpha,2-beta,4-beta,5-alpha,7-beta)) Oxitropium bromide CRS Oxitropiumbromid Tersigan N-Ethylnorscopolammonium bromide Oxivent ba-253-br-l Ventilat n-ethyl-norscopolaminemethobromide N-Ethylscopolammonium bromide (6CI, 7CI) tersigat 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-ethyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide, (1a,2b,4b,5a,7b)- (9CI) 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-ethyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, [7(S)-(1a,2b,4b,5a,7b)] Bromure d'oxitropium Hyoscine ethobromide N-Ethylnorscopolamine methylbromide oxitropiobromuro 3-oxa-9-azoniatricyclo(3.3.1.0(sup2,4))nonane,9-ethyl-7-(3-hydroxy-1-oxo-2-ph |
| Description | Oxitropium bromide is an mAChR antagonist used as an anticholinergic bronchodilator drug for the treatment of asthma and chronic obstructive pulmonary disease. |
|---|---|
| Related Catalog | |
| Target |
mAChR[1] |
| In Vitro | Oxitropium bromide is a muscarinic antagonist which blocks musucarinic acetylcholine receptors (mAChR). Incubation with oxitropium bromide of untreated diaphragm muscle and diaphragm muscle injected with endotoxin does not increase the force-frequency curves dose-dependently in vitro; however, it causes both types of muscle to be fatigue resistant[1]. |
| In Vivo | Oxitropium bromide inhalation shifts force-frequency curves upward at 2 h after inhalation and inhibits the decrease of force-frequency curves due to endotoxin injection in vivo[1]. Oxitropium bromide strongly and persistently inhibits the acetylcholine (ACh)-induced resistance. The increase in resistance induced by histamine, serotonin, leukotriene D4 or antigen is prevented by oxitropium bromide oxitropium bromide[2]. Inhalation of the anticholinergic agent oxitropium bromide at doses of 1.5 μg and higher greatly attenuates the decrease in mucus score produced by intravenous histamine but not by inhaled histamine[3]. |
| Animal Admin | Mice: In the oxitropium bromide inhalation group, animals are given 2 puffs of inhalation from a oxitropium bromide MDI (metered dose inhaler) via a 75-mL spacer, and then diaphragm muscles are dissected and measured as to contractility immediately, 1 hour, 2 hours and 4 hours later (n=5 animals each). An animal is placed in a centrifugal tube (inner diameter=30 mm) with a round hole (diameter=10 mm) in the bottom, its nose and mouth being exposed through the hole to breath. An oxitropium bromide MDI (metered dose inhaler) releases 2 puffs into a spacer attached to the tube. Aerosols of oxitropium bromide are inhaled for about 10 seconds, while the animal is breathing spontaneously through the hole of the tube[1]. |
| References |
| Melting Point | 203-204° (dec) |
|---|---|
| Molecular Formula | C19H26BrNO4 |
| Molecular Weight | 412.31800 |
| Exact Mass | 411.10500 |
| PSA | 59.06000 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~%
30286-75-0 |
| Literature: Journal of the American Chemical Society, , vol. 78, p. 3448,3452 |
|
~84%
30286-75-0 |
| Literature: Banholzer; Pook Arzneimittel-Forschung/Drug Research, 1985 , vol. 35, # 1 A p. 217 - 228 |
|
~%
30286-75-0 |
| Literature: Arzneimittel-Forschung/Drug Research, , vol. 35, # 1 A p. 217 - 228 |
|
~%
30286-75-0 |
| Literature: Arzneimittel-Forschung/Drug Research, , vol. 35, # 1 A p. 217 - 228 |
| Precursor 5 | |
|---|---|
| DownStream 2 | |